Skip to content
Back to skills

Endo Vitd No Testing 50to74

ASecurity

This skill recommends against routine 25(OH)D testing in asymptomatic adults aged 50–74 years. It is triggered by questions such as "Should I order a vitamin D level for this patient aged 50-74?" or "Is vitamin D testing indicated for asymptomatic middle-aged adults?"

  • 12 stars
  • 0 votes
  • 0 copies
  • 1 view
  • Added September 9, 2026
devopsrailstesting

Works with

  • cli

Security analysis

A100/100

Scanned September 9, 2026

npx -y skills add dromlakhani/MD2SKILL --skill endo-vitd-no-testing-50to74 --agent claude-code

Installs into .claude/skills of the current project.

Are you the author of Endo Vitd No Testing 50to74?

Add the live security badge to your README. It updates with every re-scan.

Security grade badge for Endo Vitd No Testing 50to74
[![Security: A — Skills Directory](https://www.skillsdirectory.com/api/skills/dromlakhani-endo-vitd-no-testing-50to74/badge)](https://www.skillsdirectory.com/skills/dromlakhani-endo-vitd-no-testing-50to74)

More formats (shields.io, HTML) on the badges page. Keep it an A: scan every change in CI with Pro.

Download with Pro
SKILL.md
---
name: endo-vitd-no-testing-50to74
description: This skill recommends against routine 25(OH)D testing in asymptomatic adults aged 50–74 years. It is triggered by questions such as "Should I order a vitamin D level for this patient aged 50-74?" or "Is vitamin D testing indicated for asymptomatic middle-aged adults?"
---

# Against routine vitamin D testing in adults 50-74

## STEP 1 — Gather Information
Collect patient age (50-74 years), presence of symptoms suggestive of vitamin D deficiency (e.g., bone pain, proximal muscle weakness), known conditions that alter vitamin D metabolism (malabsorption, CKD, hyperparathyroidism, osteoporosis treatment), and any established indications for 25(OH)D testing (hypocalcemia, monitoring therapy). If none, proceed.

## STEP 2 — Rule In / Rule Out
Rule in if patient has an established indication for testing (symptoms of deficiency, malabsorption, CKD stage 4-5, hyperparathyroidism, osteoporosis treatment monitoring, or other specific clinical indication). Rule out if asymptomatic and no such indications.

## STEP 3 — Classify or Stratify
Classify as "no routine testing indicated" when patient is aged 50-74, asymptomatic, and lacks established indications for 25(OH)D testing. No further stratification needed.

## STEP 4 — Decide
Do not order a 25(OH)D test. Discuss empiric vitamin D supplementation only if patient meets criteria for supplementation per other guideline recommendations (e.g., high-risk prediabetes, pregnancy, age ≥75), not based on test results.

## Clinical Guardrails / Mimics / Pitfalls
Do not use 25(OH)D levels to guide supplementation in this age group; avoid testing for cost and equity reasons; beware of false-positive low results leading to unnecessary treatment; do not extrapolate to patients with malabsorption, CKD, or osteoporosis where testing may be warranted.

## Concrete Clinical Example
A 62-year-old man with no bone or muscle symptoms, normal renal function, and no history of osteoporosis asks whether he should have a vitamin D level checked. The clinician advises against routine testing, discusses diet and sun exposure, and notes that empiric supplementation is not indicated without specific risk factors.

**Source:** Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, DOI: 10.1210/clinem/dgae290

Attribution

Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.

Comments

Loading comments…

Newsletter

Get the weekly list of safe new skills, and the ones we pulled.